Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELISA-2
NL-OMON24053Active, not recruiting
- Sponsor
- AWJ van ¡¦t Hof, MD, PhD Dept of Cardiology Isala Klinieken, locatie Weezenlanden Groot Wezenland 20 8011 JW, Zwolle, the Netherlands
- Start
- Apr 2002
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tirofiban, clopidogrel and dexamethasone in acute coronary syndrome (ACS) and non–ST-segment elevation acute coronary syndrome (NSTE-ACS) (2 arms), sponsored by AWJ van ¡¦t Hof, MD, PhD Dept of Cardiology Isala Klinieken, locatie Weezenlanden Groot Wezenland 20 8011 JW, Zwolle, the Netherlands. Started Apr 2002; status: active, not recruiting.
02
Drugs
tirofibanclopidogreldexamethasone
03
Conditions
acute coronary syndrome (ACS)non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NL-OMON24053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24053.